These results demonstrate that checkpoint blockade has merit in T-cell lymphomas, but a deeper understanding of the role of PD-1/PD-L1 in tumorigenesis and immune evasion is needed to safely continue evaluation. Here, CD274 is linked to T-cell non-Hodgkin lymphoma.